Alembic Pharmaceuticals Balance Sheet Annual

Trade

BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | Sector: Biotechnology & Drugs

1,096.95 +55.15 (5.29%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	120.21	75.48	61.09	98.06
Short Term Investments	20.77	-	0.00	186.97
Cashand Short Term Investments	140.98	75.48	61.09	285.03
Accounts Receivable- Trade Net	1,024.84	1,046.40	807.13	348.58
Total Receivables Net	1,065.87	1,134.06	836.21	370.56
Total Inventory	1,643.54	1,528.77	1,662.08	1,549.64
Other Current Assets Total	228.17	116.39	264.34	411.04
Total Current Assets	3,078.56	2,910.02	2,860.79	2,652.00
Property/ Plant/ Equipment Total- Net	3,071.07	2,999.73	3,947.26	3,647.15
Long Term Investments	93.02	96.33	118.40	49.31
Note Receivable- Long Term	33.30	53.74	34.88	36.70
Other Long Term Assets Total	169.63	123.01	5.88	0.02
Total Assets	6,445.58	6,182.83	7,122.03	6,708.98
Accounts Payable	735.64	679.81	706.39	668.77
Current Portof LT Debt/ Capital Leases	450.28	16.92	214.97	312.16
Other Currentliabilities Total	269.07	230.21	260.96	182.83
Total Current Liabilities	1,454.99	1,636.92	1,716.53	1,280.84
Capital Lease Obligations	62.88	69.23	72.14	71.54
Total Long Term Debt	62.88	69.23	72.14	271.43
Total Debt	513.16	722.02	717.11	583.61
Other Liabilities Total	109.51	106.21	95.81	85.53
Total Liabilities	1,627.38	1,812.36	1,884.48	1,642.01
Common Stock Total	39.31	39.31	39.31	39.31
Retained Earnings( Accumulated Deficit)	4,778.89	3,568.69	4,449.12	4,279.96
Total Equity	4,818.20	4,370.47	5,237.55	5,066.97
Total Liabilities Shareholders' Equity	6,445.58	6,182.83	7,122.03	6,708.98
Total Common Shares Outstanding	19.66	19.66	19.66	19.66
Tangible Book Valueper Share Common Eq	245.12	222.34	258.58	241.31
Prepaid Expenses	-	55.32	37.07	35.73
Property/ Plant/ Equipment Total- Gross	-	3,467.49	2,600.95	2,365.72
Accumulated Depreciation Total	-	-1,069.06	-859.49	-662.84
Intangibles Net	-	0.00	154.82	323.80
Accrued Expenses	-	74.11	104.21	117.06
Notes Payable/ Short Term Debt	-	635.87	430.00	0.02
Additional Paid- In Capital	-	748.39	748.39	748.39
Unrealized Gain( Loss)	-	0.57	0.21	0.00
Other Equity Total	-	13.51	0.52	-0.69
Long Term Debt	-	-	0.00	199.89
Deferred Income Tax	-	-	0.00	4.21